Clinical Study of Drug-coated Balloon Dilation in the Treatment of Femoral Popliteal Artery Disease  

作　　者：LAIHuaping 

机构地区：[1]Ganzhou Municipal Hospital, Ganzhou Jiangxi 341000, China

出　　处：《外文科技期刊数据库(文摘版)医药卫生》2022年第7期069-072,共4页

摘　　要：Objective: to investigate the clinical effect of drug-coated balloon dilation in the treatment of femoral popliteal artery disease. Methods: 30 patients with femoral and popliteal artery disease who were treated in Ganzhou City Hospital from November 2016 to October 2018 were selected as the research object. All patients were treated with drug-coated balloon dilatation. The patients were followed up for 6 to 18 months after operation. The restenosis rate, late lumen loss and the rate of target lesion revascularization were counted. Results: all 30 patients successfully completed the operation with a success rate of 100%. 3 patients had hematoma at puncture site during perioperative period;The first-stage unblocking rate of target lesion was 86.67%, 66.67% and 53.33% at 6, 12 and 18 months after operation respectively. The restenosis rate was 30.00% within 18 months after operation. The late loss of lumen was (0.35±0.06)mm, (0.70±0.07)mm, (1.57±0.06)mm at 6, 12 and 18 months postoperatively. The vascular reconstruction rate of target lesion was 20.00% 6-18 months after operation. Conclusion: the drug-coated balloon dilatation has a significant clinical effect in the treatment of femoral popliteal artery disease, which can potentially reduce the restenosis rate, late lumen loss and the target lesion revascularization rate. The effect is durable and has promotional value in clinical practice.

关 键 词：drug-coated balloon dilation femoral popliteal artery lesions restenosis rate late lumen loss re 

分 类 号：R54[医药卫生—心血管疾病]